Kevin Kotler Recro Pharma, Inc

As of May 24, 2018


Kevin Kotler Net Worth

  • Net worth is estimated to be at least $535.55M
  • Owns at least 2,048,025 units of Recro Pharma, Inc stock
  • Sold an estimated value of $9.54M in the last 4 years at Recro Pharma, Inc

Kevin Kotler Trading

  • Largest purchase of shares was 646,553 units , worth over $7.5M on July 9, 2015
  • Largest sale of shares was 222,616 units , worth over $2.13M on November 30, 2017
  • In total has made about 11 transactions over 4 years
  • Usually trades in December, with the busiest year in 2017

Broadfin Healthcare Master Fund Ltd, Broadfin Capital LLC, KEVIN KOTLER

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kevin Kotler Mailing Address

  • Mailing address is C/o Broadfin Capital, Llc 300 Park Avenue, 25th Floor New York NY 10022 NY

Recro Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. David Enloe, Jr. 2020 $10,577 - $660,001 $400,544 - $1,678 $1,072,800
Ryan D. Lake 2020 $198,985 $48,000 $1,058,040 $744,327 $107,640 $24,673 $2,181,665
Ryan D. Lake 2019 $319,777 $69,440 $623,276 $334,200 $138,880 $44,038 $1,529,611
Gerri Henwood 2020 $308,654 $111,240 - - - $21,166 $441,060
Gerri Henwood 2019 $553,846 - $2,608,537 $1,062,199 $360,000 $38,402 $4,622,984
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm

Recro Pharma, Inc Insider Trading

  • The most recent transaction was 602 units bought on January 19, 2022 by David Enloe Jr worth over $1.01K
  • In the last 8 years, insiders at Recro Pharma, Inc sold an estimated value of $26.27M and bought an estimated value of $15.86M
  • The most active traders are By: Ryan D. Lake, Chief Financial Officer,  Geraldine Henwood, Director,  and Scp Vitalife Partners Ii Lp
  • Insider trading is most common in December, with the busiest year in 2017

Recro Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1